{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:41:08Z","timestamp":1780375268429,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.etap.2014.06.011","type":"journal-article","created":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T10:02:08Z","timestamp":1404554528000},"page":"316-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of the in vitro cytogenotoxicity profile of antipsychotic drug haloperidol using human peripheral blood lymphocytes"],"prefix":"10.1016","volume":"38","author":[{"given":"Goran","family":"Gajski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Geri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Garaj-Vrhovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2014.06.011_bib0005","article-title":"Protective effect of Calligonum comosum on haloperidol-induced oxidative stress in rat","author":"Abdel-Sattar","year":"2012","journal-title":"Toxicol. Ind. Health."},{"key":"10.1016\/j.etap.2014.06.011_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10565-004-5352-4","article-title":"Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes","volume":"20","author":"Abou-Eisha","year":"2004","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.etap.2014.06.011_bib0015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1192\/bjp.179.4.290","article-title":"Systematic meta-review of depot antipsychotic drugs for people with schizophrenia","volume":"179","author":"Adams","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.etap.2014.06.011_bib0020","first-page":"699","article-title":"Cytogenetic effects of psychotropic drug haloperidol on human lymphocytes","volume":"34","author":"Ahuja","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.etap.2014.06.011_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","article-title":"DNA damage in bipolar disorder","volume":"153","author":"Andreazza","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mrgentox.2009.04.011","article-title":"Species-level differences between mice and rats in regards to micronucleus induction with the hypothermia-inducing drug haloperidol","volume":"676","author":"Asanami","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00001756-199512000-00085","article-title":"Haloperidol-induced cell death \u2013 mechanism and protection with vitamin E in vitro","volume":"7","author":"Behl","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.etap.2014.06.011_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(96)00126-6","article-title":"Oxidative stress-resistant cells are protected against haloperidol toxicity","volume":"717","author":"Behl","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-198733010-00002","article-title":"Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis","volume":"33","author":"Beresford","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.etap.2014.06.011_bib0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0027-5107(94)90306-9","article-title":"Microgel electrophoresis assay (comet test) and SCE analysis in human lymphocytes from 100 normal subjects","volume":"307","author":"Betti","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tox.2009.04.056","article-title":"Genotoxic and carcinogenic effects of antipsychotics and antidepressants","volume":"261","author":"Brambilla","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.etap.2014.06.011_bib0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00004714-198908000-00003","article-title":"A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia","volume":"9","author":"Chouinard","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.etap.2014.06.011_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/mutage\/gem051","article-title":"The comet assay: topical issues","volume":"23","author":"Collins","year":"2008","journal-title":"Mutagenesis"},{"key":"10.1016\/j.etap.2014.06.011_bib0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000321623","article-title":"Quetiapine, olanzapine and haloperidol affect human plasma lipid peroxidation in vitro","volume":"63","author":"Dietrich-Muszalska","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.etap.2014.06.011_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijbiomac.2011.03.007","article-title":"Beta-glucan from Saccharomyces cerevisiae reduces plasma lipid peroxidation induced by haloperidol","volume":"49","author":"Dietrich-Muszalska","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.etap.2014.06.011_bib0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11064-011-0642-8","article-title":"Epicatechin inhibits human plasma lipid peroxidation caused by haloperidol in vitro","volume":"37","author":"Dietrich-Muszalska","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0085","series-title":"Current Protocols in Immunology","first-page":"1","article-title":"Morphological and biochemical assays of apoptosis","author":"Duke","year":"1992"},{"key":"10.1016\/j.etap.2014.06.011_bib0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-1161(85)90015-9","article-title":"Measurement of micronuclei in lymphocytes","volume":"147","author":"Fenech","year":"1985","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","article-title":"HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures","volume":"534","author":"Fenech","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/mutage\/geq052","article-title":"Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells","volume":"26","author":"Fenech","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.etap.2014.06.011_bib0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/carcin\/3.2.223","article-title":"Leukaemogenic and mutagenic activity of the butyrophenon, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone (haloperidol)","volume":"3","author":"Fey","year":"1982","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.etap.2014.06.011_bib0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mehy.2012.03.026","article-title":"Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review","volume":"79","author":"Fond","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.etap.2014.06.011_bib0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.taap.2008.03.013","article-title":"Cytogenetic status and oxidative DNA-damage induced by atorvastatin in human peripheral blood lymphocytes: standard and Fpg-modified comet assay","volume":"231","author":"Gajski","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.etap.2014.06.011_bib0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020070089","article-title":"Haloperidol-induced neurotoxicity \u2013 possible implications for tardive dyskinesia","volume":"107","author":"Galili","year":"2000","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.etap.2014.06.011_bib0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2011.08.010","article-title":"Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells","volume":"36","author":"Gass\u00f3","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.etap.2014.06.011_bib0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/A:1015152021192","article-title":"Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms","volume":"21","author":"Gil-ad","year":"2001","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.etap.2014.06.011_bib0130","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","author":"Gilman","year":"1990"},{"key":"10.1016\/j.etap.2014.06.011_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/bjp.195.52.s20","article-title":"First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies","volume":"52","author":"Haddad","year":"2009","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.etap.2014.06.011_bib0300","series-title":"Cytogenetic Analysis for Radiation Dose Assessment. A Manual, Technical Reports Series No. 405","author":"International Atomic Energy Agency","year":"2001"},{"key":"10.1016\/j.etap.2014.06.011_bib0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clinbiochem.2011.03.135","article-title":"Correlation of haloperidol levels between saliva and plasma of acutely ill schizophrenic patients","volume":"44","author":"Jain","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.etap.2014.06.011_bib0150","series-title":"Antipsychotic Agents and Lithium. Basic and Clinical Pharmacology","author":"Katzung","year":"2001"},{"key":"10.1016\/j.etap.2014.06.011_bib0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mrgentox.2003.07.005","article-title":"Report from the in vitro micronucleus assay working group","volume":"540","author":"Kirsch-Volders","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0160","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2007-1017373","article-title":"Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months\u2019 treatment for relapse prevention","volume":"18","author":"Kissling","year":"1985","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.etap.2014.06.011_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0027-5107(02)00075-1","article-title":"Chromosome aberrations: past, present and future","volume":"504","author":"Natarajan","year":"2002","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0170","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.etap.2014.06.011_bib0175","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1046\/j.1471-4159.2000.0752327.x","article-title":"Haloperidol-induced neuronal apoptosis: role of p38 and c-Jun-NH(2)-terminal protein kinase","volume":"75","author":"Noh","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.etap.2014.06.011_bib0180","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0006-2952(99)00156-2","article-title":"Effects of psychotropic drugs on cell proliferation and differentiation","volume":"58","author":"Nordenberg","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2014.06.011_bib0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-3223(94)90648-3","article-title":"Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration","volume":"36","author":"Pai","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.etap.2014.06.011_bib0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-3701-1-12","article-title":"Neuroprotective effects of alpha lipoic acid on haloperidol-induced oxidative stress in the rat brain","volume":"1","author":"Perera","year":"2011","journal-title":"Cell Biosci."},{"key":"10.1016\/j.etap.2014.06.011_bib0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0893-133X(01)00364-5","article-title":"Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidol-associated neurotoxicity","volume":"26","author":"Post","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.etap.2014.06.011_bib0200","first-page":"CD009377","article-title":"Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)","volume":"11","author":"Powney","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.etap.2014.06.011_bib0205","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1471-4159.1998.71031002.x","article-title":"Induction of reactive oxygen species in neurons by haloperidol","volume":"71","author":"Sagara","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.etap.2014.06.011_bib0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0027-5107(00)00075-0","article-title":"Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis","volume":"455","author":"Singh","year":"2000","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1383-5742(01)00055-2","article-title":"A review of the genotoxicity of marketed pharmaceuticals","volume":"488","author":"Snyder","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/1-59259-973-7:275","article-title":"The comet assay: a sensitive genotoxicity test for the detection of DNA damage and repair","volume":"314","author":"Speit","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.etap.2014.06.011_bib0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/bjp.195.52.s13","article-title":"Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review","volume":"52","author":"Taylor","year":"2009","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.etap.2014.06.011_bib0235","series-title":"Physicians\u2019 Desk Reference","author":"Thomson","year":"2005"},{"key":"10.1016\/j.etap.2014.06.011_bib0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing","volume":"35","author":"Tice","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.etap.2014.06.011_bib0245","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00702-004-0109-z","article-title":"Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol","volume":"111","author":"Ukai","year":"2004","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.etap.2014.06.011_bib0250","unstructured":"U.S. Food and Drug Administration. 2009. Available from: http:\/\/www.accessdata.fda.gov."},{"key":"10.1016\/j.etap.2014.06.011_bib0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/01480548709042989","article-title":"Mutagenic and leukemogenic activity of haloperidol: a negative study","volume":"10","author":"Van Cauteren","year":"1987","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.etap.2014.06.011_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0922-4106(93)90029-9","article-title":"Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture","volume":"244","author":"Vilner","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.etap.2014.06.011_bib0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1523\/JNEUROSCI.15-01-00117.1995","article-title":"Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability","volume":"15","author":"Vilner","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.etap.2014.06.011_bib0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","article-title":"Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target","volume":"126","author":"Wiklund","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.etap.2014.06.011_bib0280","first-page":"15","article-title":"A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients","volume":"1","author":"Wistedt","year":"1986","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.etap.2014.06.011_bib0275","first-page":"804","article-title":"A clinical double-blind comparison between haloperidol decanoate and fluphenazine decanoate","volume":"35","author":"Wistedt","year":"1984","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.etap.2014.06.011_bib0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.1991.tb01414.x","article-title":"Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study","volume":"84","author":"Wistedt","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.etap.2014.06.011_bib0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/toxsci\/kfl192","article-title":"Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection","volume":"97","author":"Witte","year":"2007","journal-title":"Toxicol. Sci."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668914001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668914001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T12:49:25Z","timestamp":1565614165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668914001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1382668914001549"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2014.06.011","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the in vitro cytogenotoxicity profile of antipsychotic drug haloperidol using human peripheral blood lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2014.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}